Clinical Study of MNC-168 Enteric-coated Capsule in the Treatment of Advanced Intestinal Solid Tumor

NCT05383703 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Solid Tumors

Interventions

DRUG: Treatment of MNC-168 enteric-coated capsules as a single oral drug

Sponsor

Moon (Guangzhou) Biotechnology Co., Ltd.